Streetbeat News

Regulatory

AEON

AEON Biopharma announced topline results from its Phase 2 trial of ABP-450 for the preventive treatment of episodic migraine. The treatment showed a positive effect but did not meet statistical significance versus placebo due to a higher-than-expected placebo response. However, the study demonstrated statistical significance on multiple secondary and exploratory endpoints. The data supports the decision to advance into Phase 3, anticipated in 2H 2024. An ongoing Phase 2 trial for the preventive treatment of chronic migraine has enrolled over 430 subjects, with enrollment completion expected in Q4 2023 and topline data in 2H 2024.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 8:08 pm

CAPR

Capricor Therapeutics (NASDAQ:CAPR) will host a webinar with Parent Project Muscular Dystrophy (PPMD) to review regulatory details and provide clinical updates on its ongoing HOPE-3, Phase 3 clinical trial of CAP-1002 for treating Duchenne muscular dystrophy. The webinar will be held on October 25, 2023.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 8:03 pm

MCB

Metropolitan Commercial Bank is set to pay around $30 million in fines due to misuse of prepaid card accounts. The Federal Reserve stated that the bank opened these accounts for illicit actors who illegally obtained unemployment insurance benefits.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 8:02 pm

DNA

Ginkgo Bioworks (NYSE:DNA) and the Government of Serbia have announced a Memorandum of Understanding (MoU) to collaborate in support of Serbia's bioeconomy vision. The partnership will establish a Startup Accelerator that leverages Ginkgo's platform and expertise to support Serbian companies in the bioeconomy sector. The collaboration will also explore partnerships to develop and implement new biomonitoring capabilities in Serbia. Companies at Serbia's BIO4 campus will have opportunities to engage Ginkgo staff and access Ginkgo expertise on site.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 8:02 pm

GILD

IKNA

Gilead Sciences has reported a 6.7% stake in Ikena Oncology, according to a 13G filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 7:38 pm

IGC

IGC Pharma has been granted a European patent for a 'Cannabinoid Composition and Method for Treating'. This could potentially open up new markets and revenue streams for the company.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 7:31 pm

TSLA

Venture capitalist Marc Andreessen has criticized those advocating for a slowdown in AI development, equating it to murder. He believes AI is a universal problem solver and any deceleration in its development will cost lives. His views contrast with those of Tesla CEO Elon Musk, who has warned of the profound risks AI presents to society. Reports suggest the EU is planning to propose stricter rules for AI development.

Portfolio Pulse from Adam Eckert

October 19, 2023 | 6:51 pm

MLSS

Milestone Scientific Inc has filed for a mixed shelf offering of up to $45 million, according to a SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 6:47 pm

CLF

The Justice Department and EPA have modified a 2015 consent decree with Cleveland-Cliffs Steel Corporation (formerly AK Steel) to resolve Clean Air Act violations at its Dearborn, Michigan, steel manufacturing plant. The modification requires Cleveland-Cliffs to undertake additional measures costing over $100 million to reduce visible emissions and curtail emissions of manganese and lead. The company will also pay a civil penalty of $81,380 to the state of Michigan for violating state permit's opacity, lead and manganese limits.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 6:25 pm

EWJ

FXI

KODK

The U.S. Department of Commerce has initiated antidumping and countervailing duty investigations into aluminum lithographic printing plates from China and Japan. The petitioner is Eastman Kodak Company. The alleged dumping margins are 107.62% for China and 23.46% for Japan. The investigations could impact the import volumes and values of these plates from both countries.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 6:24 pm